REFERENCES
- Tozzoli R, Bizzaro N, Tonutti E etal., Guidelines for the labora-tory use of autoantibody tests in the diagnosis and monitoring of autoimmune rheumatic diseases. Am] Clin Pathol 2002;117: 316–24.
- Tan EM, Cohen AS, Fries JF etal. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25: 1271–77.
- Hochberg MC. Updating the American College of Rheumatol-ogy revised criteria for the classification of systemic lupus ery-thematosus (Letter). Arthritis Rheum 1997;40: 1725.
- Ter Borg EJ, Horst G, Hummel EJ, Limburg PC, Kallenberg CG. Measurement of increases in anti-double-stranded DNA anti-body levels as a predictor of disease exacerbation in systemic lupus erythematosus. A long-term, prospective study. Arthritis Rheum 1990;33:634–43.
- Linnik MD, Hu JZ, Heilbrunn KR et al., Relationship between anti-double-stranded DNA antibodies and exacerbation of renal disease in patients with systemic lupus erythematosus. Arthritis Rheum 2005;52: 1129–37.
- Mielnik P, Wiesik-Szewczyk E, Olesinska M, Chwalinska-Sad-owska H, Zabek J. Clinical features and prognosis of patients with idiopathic inflammatory myopathies and anti-Jo-1 anti-bodies. Autoimmunity 2006;39: 243–7.
- Peene I, Meheus L, Veys EM, De Keyser F. Detection and iden-tification of antinuclear antibodies (ANA) in a large and con-secutive cohort of serum samples referred for ANA testing. Ann Rheum Dis 2001;60: 1131–6.
- Kang I, Siperstein R, Quan T, Breitenstein ML. Utility of age, gender, ANA titer and pattern as predictors of anti-ENA and -dsDNA antibodies. Clin Rheumatol 2004;23: 509–15.
- Dellavance A, Viana VS, Leon EP, Bonfa ES, Andrade LE, Leser PG.The clinical spectrum of antinuclear antibodies associated with the nuclear dense fine speckled immunofluorescence pattern.] Rheumatol 2005;32: 2144–49.
- Meheus L, Van Venrooij WJ, Wiik A, etal. Multicenter validation of recombinant, natural and synthetic antigens used in a single multiparameter assay for the detection of specific anti-nuclear autoantibodies in connective tissue disorders. Clin Exp Rheu-matol 1999;17: 205–14.
- Pottel H, Wiik A, Locht H etal. Clinical optimization and mul-ticenter validation of antigen-specific cut-off values on the INNO-LIA ANA update for the detection of autoantibodies in connective tissue disorders. Clin Exp Rheumatol 2004;22: 579–88.
- Van Venrooij W, Charles P, Maini R. The consensus workshops for the detection of auto-antibodies to intracellular antigens in rheumatic diseases. Jimmunol Methods 1991140: 181–89.
- De Vlam K, De Keyser F, Verbruggen G etal., Detection and identification of antinuclear autoantibodies in the serum of normal blood donors. Clin Exp Rheumatol 1993;11: 393–97.
- Nilsson B.O., Skogh T, Ernerudh J etal., Antinuclear antibodies in the oldest-old women and men.J Autoimmun 2006;27: 281–88
- Kim WR, Lindor KD, Locke III GR etal. Epidemiology and natural history of primary biliary cirrhosis in a U.S. community. Gastro-enterology 2000;119: 1631–36.